SystImmune, Inc. to Present New Data from Oncology Programs at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2023

/PRNewswire/ -- Systimmune, Inc. (SystImmune) announced today that it will present clinical data from its lead programs at the ASCO Annual Meeting 2023 in...

Related Keywords

Chicago ,Illinois ,United States ,Martin Olivo ,Yi Zhu ,Securities Exchange ,Systimmune Inc ,While Systimmune Inc ,Presentation Details ,Immune Programs Profiled ,Growth Factor Receptors ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Investigational New Drug ,